disulfiram has been researched along with cupric chloride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SH; Liang, YC; Lin, JK; Lin-Shiau, SY; Liu, SH | 1 |
| Babushkin, T; Hait-Darshan, R; Malik, Z | 1 |
| An, H; Cho, TM; Cho, Y; Kim, JY; Lee, N; Oh, E; Seo, JH; Sung, D | 1 |
| An, H; Cho, TM; Cho, Y; Kim, JY; Kim, YJ; Lee, N; Oh, E; Seo, JH; Sung, D | 1 |
| Al-Tamimi, J; Alhazza, IM; Aman, S; Ebaid, H; Hassan, I; Khan, AA; Qamar, W; Rady, AM | 1 |
5 other study(ies) available for disulfiram and cupric chloride
| Article | Year |
|---|---|
Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu(2+) complex.
Topics: Animals; Animals, Newborn; Apoptosis; Astrocytes; Caspase 3; Caspases; Cells, Cultured; Cerebral Cortex; Copper; Disulfiram; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Free Radicals; Glutathione; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Mitogen-Activated Protein Kinases; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar | 2001 |
Regulation of heme synthesis and proteasomal activity by copper: possible implications for Wilson's disease.
Topics: Adenosine Triphosphatases; Carcinoma, Hepatocellular; Cation Transport Proteins; Cell Line, Tumor; Cell Survival; Copper; Copper-Transporting ATPases; Disulfiram; Down-Regulation; Enzyme Inhibitors; Heme; Hepatocytes; Hepatolenticular Degeneration; Humans; Hydroxymethylbilane Synthase; Liver Neoplasms; Porphobilinogen Synthase; Proteasome Endopeptidase Complex; Protoporphyrins; Reactive Oxygen Species; Ubiquitin | 2009 |
Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Copper; Cyclin-Dependent Kinase Inhibitor p27; Disulfiram; Dose-Response Relationship, Drug; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Retinal Dehydrogenase; Signal Transduction; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
Topics: Animals; Anoikis; Antineoplastic Agents; Calpain; Cell Line, Tumor; Cell Movement; Cell Proliferation; Copper; Cytoskeleton; Disulfiram; Dose-Response Relationship, Drug; Enzyme Activation; Female; Focal Adhesions; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Proteolysis; Signal Transduction; Time Factors; Triple Negative Breast Neoplasms; Tumor Burden; Vimentin; Xenograft Model Antitumor Assays | 2017 |
Restrained management of copper level enhances the antineoplastic activity of imatinib in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chemotherapy, Adjuvant; Copper; Disulfiram; Drug Synergism; Imatinib Mesylate; Metabolism; Neoplasms, Experimental; Rats; Treatment Outcome | 2018 |